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RODENTICIDAL ACTIVITY OF BROMADIOLONE—A NEW ANTICOAGULANT 
ADRIAN P. MEEHAN, Chief Biologist, Rentokil Limited, Felcourt, East Grinstead, Sussex, England 
ABSTRACT:  Bromadiolone, a new anticoagulant rodenticide, has been evaluated against laboratory rats 
and mice. Kill of both species was excellent, even when bromadiolone was offered for only one day in 
the presence of alternative food. Effectiveness against homozygous warfarin resistant rats was also 
demonstrated. Limited field trials on farms showed that after baiting for seven days with bromadiolone, 
warfarin resistant rat populations were substantially reduced although subsequent re-infestation 
occurred. Longer or continuous periods of baiting with bromadiolone would almost certainly prevent 
population increase, but government restrictions on the amount of bait approved for the trials did not 
allow this to be demonstrated. 
INTRODUCTION 
The introduction of anticoagulants stands out as the major development in rodent control in the 
last twenty-five years. But in 1958, a population of Rattus norvegicus, in Scotland, became resistant 
to the most commonly used anticoagulant, warfarin (Boyle 1960) - a problem which was subsequently 
recognized in other parts of Britain. Since then anticoagulant resistance has been found in a number of 
rodent species in various parts of the world, including the U.S.A. This has been well-documented and 
Kaukeinen (1977) has produced an extensive bibliography. Generally there has been cross-resistance, to 
a greater or lesser degree, to all of the more established anticoagulants. 
Recently, however, new anticoagulants with the ability to control these resistant animals have 
been synthesized. The first to be marketed was difenacoum and Bull (1976) has reviewed the properties 
of this anticoagulant. More recently, Rennison and Dubock (1978) have field tested brodifacoum, an 
analogue of difenacoum. 
Bromadiolone, is another similar type compound, which is also capable of controlling warfarin 
resistant rats and mice. Marsh (1976) and Grand (1976) have shown that bromadiolone has activity 
against a wide range of rodents, including gophers, ground squirrels, various "field" mice and voles. 
Bromadiolone is a hydroxy coumarin with the full chemical name: - 4 - hydroxy - 3 - coumarinyl - 
3 - phenyl - 3, 4 - bromo 4 - biphenyl, - 1 - proponal - 1 (Fig. 1). 
 
Fig. 1. Structure of bromadiolone. 
Bromadiolone acts as a classical indirect anticoagulant, i.e. it interferes with Vitamin K activity, 
but its potency is about 10 times greater than that of warfarin in rabbits (Grand loc. cit.). This 
author also describes laboratory and field tests with bromadiolone against rats carried out in France. 
The present paper gives details of tests with bromadiolone against laboratory strains of Rattus 
norvegicus and Mus musculus particularly in feeding tests. Preliminary results from field trials in 
England against warfarin resistant R. norvegicus are also given. 
MATERIALS AND METHODS Laboratory Studies
T.O. mice and Wistar rats were used for both the oral dosing and feeding studies. Mice weighed 
approximately 24-26g and rats 150-200g and equal numbers of males and females were used in all tests. 
122 
Homozygous warfarin resistant rats were bred by ourselves from a small number originally 
obtained from the laboratories of Ward-Blenkinsop Limited. 
Acute Oral Toxicity
Bromadiolone was administered to groups of ten mice and rats as a suspension in 0.6% gum tragacanth 
at five concentrations ranging from 0.2-3.2mg/kg. The dose was administered in 0.5ml of the suspension 
to mice and in 1.0ml to rats. Gum tragacanth alone was used as control. LD50’S were determined by the method of Weil (1952). 
Feeding Studies
The feeding tests were of two types - the "no-choice" test and "paired preference" test. 
The "no-choice" test involves feeding a poisoned bait alone and is designed simply to assess the 
toxicity of a rodenticide when incorporated in a bait. Likewise this is the primary objective of the 
"paired preference" test, but this also measures the relative acceptance of a similar unpoisoned 
(alternative) food, when offered in competition with the poisoned bait. 
In both types of test, bromadiolone was formulated in a medium oatmeal/sugar base at 0.0025%, 
0.005% and 0.01%, with a small amount of oil as a binder. The alternative food, when provided, was 
medium oatmeal/sugar. As a basis for comparison, a proprietary formulation of warfarin at 0.05% on 
whole wheat, BiotrolR, was used. Each concentration of test bait was offered to groups of twenty mice, 
caged in pairs, and to ten rats caged singly, with or without alternative food. 
Food consumption was assessed daily and hopper positions alternated to avoid place preference. 
After one, two and four days the experimental diets were replaced with a standard laboratory diet. 
Kill was scored for at least 14 days after the diets containing bromadiolone were withdrawn. 
Water was available at all times. The mean ambient temperature was 20°C ±_2°C and the relative 
humidity varied between 40% and 60%. 
A "paired preference" test against rats and mice was also carried out with a liquid concentrate 
of bromadiolone impregnated into whole wheat at 0.005%. This formulation was also tested against 
homozygous warfarin resistant rats in comparison with the standard warfarin formulation. Only four 
rats could be used in each test because of the small numbers available. 
Field Trials Against Rattus norvegicus
It was not possible to carry out tests against wild rodents in the laboratory, but a small number 
of preliminary field trials have been completed. 
Eight sites infested with Rattus norvegicus in the warfarin resistant area of Kent and Sussex, 
England were used. All the premises were farms and all had a long-standing rat control problem. 
Before the start of the trial, a bait containing 0.05% warfarin was laid daily for 7 days at each 
site. Large quantities of this bait were taken by rats and census baiting and visual observations 
showed that large numbers survived the treatment, confirming their resistance to warfarin. Bromadiolone, 
at 0.005% on whole wheat, was then laid at each site for seven days. This was followed by a post-
treatment census. 
All census treatments were with unpoisoned oatmeal. A "rest period" of 1 week was interposed 
between all poison and census treatments to avoid "pre-baiting". 
Takes of bait from each baiting point were assessed daily and where necessary, baits were 
replenished. When a bait was completely taken, twice the amount was replaced.  A numerical system 
of measuring "takes" was used as weighing was impractical. 
RESULTS AND DISCUSSION 
Laboratory Studies - Acute Oral Toxicity
Bromadiolone is somewhat more toxic to males than females (Table 1). It is also somewhat more 
toxic to the strains used by Rentokil than those tested by Grand (loc. cit.) who determined an acute 
oral LD50 of 1.125mg/kg for rats and of 1.75mg/kg for mice. The difference may also be due to the vehicle used for administering bromadiolone. 
Laboratory Studies - Mortality
Kill of the test animals was good, and far superior to that found with warfarin baits. Only the 
occasional animal survived. Mice (Table 2) appeared somewhat more tolerant than rats (Table 3) but 
this is experienced with most anticoagulants. 
The feeding regime made little difference to results: kill was similar whether alternative food 
was present or not and regardless of the number of days poison was fed. It would therefore appear that 
in the laboratory, bromadiolone is capable of killing rats and mice after feeding for only one night 
even at concentrations as low as 0.0025%. This supports the results of Marsh's work with Norway rats 
in one day “no. choice” tests. 
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Table 1.  The acute oral toxicity of bromadiolone (mg/kg) to rats and mice when orally dosed.
Table 2.  Food consumption and kill of T.O. mice offered bromadiolone or warfarin with and without 
alternative food. 
The interval between feeding and death was not influenced significantly by any parameter, including 
the amount of poison eaten. The mean time to death is more than 6 days for both rats and mice and only 
one animal (a mouse) died in less than four days. Some animals continued to die up to 15 days from the 
start of experiments. 
The smallest amount of bromadiolone eaten was by the test group of animals given the lowest 
concentration of bromadiolone for one day only. This was 3 and 2mg/kg respectively for mice and rats, 
but was still well in excess of the respective LD50'S. Excellent kill was achieved at even these levels. 
The number of homozygous resistant rats fed in the laboratory was small. However, when bromadiolone 
was fed to these, three out of four were killed, whereas warfarin failed to kill any. This indicates 
that even highly resistant individuals such as these are capable of being controlled by bromadiolone. 
Grand (loc. cit.) also states that bromadiolone is active against resistant rats. 
Palatability
The palatability of bromadiolone to both rats and mice was excellent when incorporated with an 
oatmeal base (Tables 2 and 3). Baits offered to mice contained a small amount of oil as a binder, and 
it was probably this which made the poison material many times more palatable than the untreated 
alternative. 
At the two lowest concentrations used, rats are unable to detect bromadiolone and in fact preferred 
the treated diet.  At the highest concentration (0.01%), rats could just detect the bromadiolone, 
whereas mice even at this level, continued to eat more treated diet than alternative. 
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Table 3.  Food consumption and kill of Wistar rats offered bromadiolone or warfarin in an oatmeal 
base with and without alternative food.
Table 4.  Food consumption and kill of Wistar rats and T.O. mice offered 0.005% bromadiolone formulated 
on whole wheat and fed in competition with alternative food. 
 
Amount eaten (g) Days to Death   
Days                    
1    2      3     4 
Mean active 
ingredient 
intake 
(mg/kg) 
Kill 
Mean Range 
Wistar Rats Poison Alt 163  128   103    84 275  373   284    208 5 20/20 5.8 4-9 
T.O. 
Mice 
Poison 
Alt 
65  42    17     19  
21  43    72     58 25 19/20 7.5 4-15 
Changing the bait base to wheat (Table 4) slightly reduced the palatability of bromadiolone to 
both rats and mice, but it was still more palatable than warfarin in similar baits. But despite the 
somewhat reduced palatability excellent kills were obtained viz. 100% and 95% for rats and mice, 
respectively. 
Field Trials
The tests were carried out in and around farm buildings in the autumn/winter of 1977. The results 
from all eight sites were similar: progress at three, typical sites is therefore reported (Fig. 2). 
After seven days baiting with 0.005% bromadiolone the rat populations judged by the takes of bait 
were minimal at all the three sites. An average reduction of over 90%. This was confirmed by visual 
observation and live trapping. However, after a 7 day interval without bait and a further 7 days post-
treatment census with oatmeal, the populations again appeared to increase. This was caused by re-
infestation of the treated buildings from surrounding land - a common occurrence in rural areas, 
particularly where food and harborage is sought by rats in the autumn. The amount of bait approved by 
the U.K. government (MAFF) for these trials was limited. Thus if sufficient bait had been available to 
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 Figure 2.  Intake of 0.005% bromadiolone bait 
and unpoisoned oatmeal post treat-
ment census bait on three typical 
farms infested with warfarin 
resistant R. norvegicus. (There is 
a seven day delay between the treat-
ment and census). 
leave it down for longer periods or continuously, complete control would have been obtained. Rennison 
and Dubock (loc. cit.) made similar conclusions when testing brodifacoum. One, four and seven-day feeds 
gave only partial control, whereas baiting for up to 25 days gave complete control. 
No untoward health incidents occurred during the tests with bromadiolone and none have been 
reported from France, where more widespread trials have been conducted. More extensive trials with 
bromadiolone are planned as soon as Government clearance is obtained. 
The greatest poisoning risk with rodenticides is to cats and dogs in the U.K. The toxicity of 
bromadiolone to these animals is lower than that of warfarin. The maximum tolerated single oral dose 
to dogs is lOmg/kg and to cats 25mg/kg. A dog would thus have to eat 20% of its body weight of 0.005% 
bait before clinical symptoms appear. The chronic toxicity to pigs is significantly lower than that of 
warfarin, but strangely bromadiolone is more toxic to chickens. Bromadiolone would thus seem to present 
no greater hazard in use, than other anticoagulants. 
CONCLUSIONS 
Bromadiolone clearly shows potential as a replacement for warfarin and other anticoagulants which 
require repeated feedings to kill. It is active against resistant rats and has a good safety margin to 
most non-target species.  The optimum conditions of use by pest control personnel in the U.K. has 
now to be documented. 
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